Financial Information

Consolidated Balance Sheet

Net Assets(¥ million)
		121th period	122th period
Settlement Date		March 2025	March 2026
Stockholders' Equity		41,477	42,074
Breakdown	Capital	5,451	5,451
	Capital Surplus	4,188	4,188
	Retained Earnings	32,480	33,419
	Treasury Stock	△642	△985
Accumulated Other Comprehensive Income		1,709	2,251
Breakdown	Valuation Difference on Other Securities	395	555
	Foreign Currency Translation Adjustment Account	203	265
	Accumulated Adjustment for Retirement Benefits	1,111	1,430
Total Net Assets		43,187	44,325
Total Liabilities and Net Assets		67,603	67,307

(¥ million)
	121th period	122th period
Month of settlement	March 2025	March 2026
Net sales	49,457	50,470
Cost of sales	34,555	35,445
Gross profit	14,902	15,025
Selling, general and administrative expenses	12,315	12,754
Other income	339	338
Other expenses	244	166
Ordinary income	2,681	2,442
Extraordinary income	-	-
Extraordinary loss	53	317
Income before income taxes	2,628	2,125
Corporate tax, etc	668	472
Net income	1,959	1,652
Net income attributable to non-controlling shareholders	-	-
Net income attributable to owners of parent	1,959	1,652

(¥ million)
	121th period	122th period
Month of settlement	March 2025	March 2026
Cash flows from operating activities	3,690	2,540
Cash flows from investing activities	△1,695	△2,238
Cash flows from financing activities	△763	△1,114
Exchange differences on cash and cash equivalents	25	17
Change in cash and cash equivalents	1,257	△795
Cash and cash equivalents at beginning of year	13,049	14,307
Cash and cash equivalents at end of year	14,307	13,512